Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Neurocrine Biosciences published KINECT-PRO study results showing INGREZZA improved patient-reported quality of life and functionality in tardive dyskinesia patients.
Insilico Medicine nominated ISM0900, an AI-driven oral Lp(a) inhibitor, as a preclinical candidate for managing cardiovascular risks on August 12, 2026.
Vanguard introduced Custom Model Portfolios on August 12, 2026, allowing financial advisors to modify existing Vanguard models for client-specific needs.
Hyland introduced Intelligent Transcripts, an AI-native solution that automates the processing of complex academic records for higher education institutions.
